Raffa Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Raffa Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14K	Buy	4 +2	+100%	+$589	﹤0.01%	979
2026 Q1	$594	Hold	2	–	–	﹤0.01%	1045
2025 Q4	$608	Hold	2	–	–	﹤0.01%	1041
2025 Q3	$681	Hold	2	–	–	﹤0.01%	991
2025 Q2	$484	Sell	2 -5	-71%	-$1.23K	﹤0.01%	1003
2025 Q1	$1.91K	Hold	7	–	–	﹤0.01%	644
2024 Q4	$1.29K	Buy	7 +5	+250%	+$1.02K	﹤0.01%	789
2024 Q3	$449	Hold	2	–	–	﹤0.01%	1000
2024 Q2	$285	Hold	2	–	–	﹤0.01%	1102
2024 Q1	$313	Hold	2	–	–	﹤0.01%	1078
2023 Q4	$361	Hold	2	–	–	﹤0.01%	1001
2023 Q3	$360	Hold	2	–	–	﹤0.01%	992
2023 Q2	$357	Hold	2	–	–	﹤0.01%	1001
2023 Q1	$431	Hold	2	–	–	﹤0.01%	987
2022 Q4	$440	Hold	2	–	–	﹤0.01%	975
2022 Q3	$270	Hold	2	–	–	﹤0.01%	1108
2022 Q2	$324	Hold	2	–	–	﹤0.01%	1075
2022 Q1	$377	Sell	2 -1	-33%	-$213	﹤0.01%	1082
2021 Q4	$813	Sell	3 -4	-57%	-$1.35K	﹤0.01%	942
2021 Q3	$2.54K	Hold	7	–	–	﹤0.01%	552
2021 Q2	$2.4K	Hold	7	–	–	﹤0.01%	570
2021 Q1	$2.44K	Buy	7 +2	+40%	+$662	﹤0.01%	584
2020 Q4	$1.29K	Buy	5 +4	+400%	+$1.1K	﹤0.01%	679
2020 Q3	$286	Buy	+1	New	+$235	﹤0.01%	858

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Raffa Wealth Management's ONC Position: Q2 2026 in Review

Raffa Wealth Management increased its BeOne Medicines Ltd (ONC) stake by 100% in Q2 2026, buying an estimated $589 and bringing the position to 4 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Raffa Wealth Management first reported a position in ONC in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.54K in Q3 2021. 273 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Raffa Wealth Management held 4 shares of BeOne Medicines Ltd worth $1.14K as of Q2 2026.
Raffa Wealth Management bought 2 BeOne Medicines Ltd shares in Q2 2026, an estimated $589.
BeOne Medicines Ltd made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #979 holding.
Raffa Wealth Management first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 24 quarters since.
Raffa Wealth Management's BeOne Medicines Ltd position peaked at $2.54K in Q3 2021.
273 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.